"Buruli ulcer and leprosy, they are intertwined": Patient experiences of integrated case management of skin neglected tropical diseases in Liberia.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
02 2020
Historique:
received: 18 07 2019
accepted: 06 01 2020
entrez: 6 2 2020
pubmed: 6 2 2020
medline: 28 4 2020
Statut: epublish

Résumé

Skin neglected tropical diseases (NTDs) such as Buruli ulcer (BU) and leprosy produce significant stigma and disability. Shared clinical presentations and needs for care present opportunities for integrated case management in co-endemic areas. As global policies are translated into local integrated services, there remains a need to monitor what new configurations of care emerge and how individuals experience them. To explore patient experiences of integrated case management for skin NTDs, in 2018, we conducted a field-based qualitative case series in a leprosy rehabilitation centre in Ganta, Liberia where BU services were recently introduced. Twenty patients with BU (n = 10) and leprosy (n = 10) participated in in-depth interviews that incorporated photography methods. We contextualised our findings with field observations and unstructured interviews with health workers. The integration of care for BU and leprosy prompted new conceptualisations of these diseases and experiences of NTD stigma. Some patients felt anxiety about using services because they feared being infected with the other disease. Other patients viewed the two diseases as 'intertwined': related manifestations of the same condition. Configurations of inter-disease stigma due to fear of transmission were buffered by joint health education sessions which also appeared to facilitate social support between patients in the facility. For both diseases, medication and wound care were viewed as the cornerstones of care and appreciated as interventions that led to rehabilitation of the whole patient group through shared experiences of healing, avoidance of physical deformities and stigma reduction. Patient accounts of intense pain during wound care for BU and inability of staff to manage severe complications, however, exposed some shortcomings of medical care for the newly integrated service, as did patient fears of long-lasting disability due to lack of physiotherapy services. Under integrated care policies, the possibility of new discourses about skin NTD identities emerging along with new configurations of stigma may have unanticipated consequences for patients' experiences of case management. The social experience of integrated medication and wound dressing has the potential to link patients within a single, supportive patient community. Control programmes with resource constraints should anticipate potential challenges of integrating care, including the need to ameliorate lasting disability and provide adequate clinical management of severe BU cases.

Sections du résumé

BACKGROUND
Skin neglected tropical diseases (NTDs) such as Buruli ulcer (BU) and leprosy produce significant stigma and disability. Shared clinical presentations and needs for care present opportunities for integrated case management in co-endemic areas. As global policies are translated into local integrated services, there remains a need to monitor what new configurations of care emerge and how individuals experience them.
METHODS
To explore patient experiences of integrated case management for skin NTDs, in 2018, we conducted a field-based qualitative case series in a leprosy rehabilitation centre in Ganta, Liberia where BU services were recently introduced. Twenty patients with BU (n = 10) and leprosy (n = 10) participated in in-depth interviews that incorporated photography methods. We contextualised our findings with field observations and unstructured interviews with health workers.
FINDINGS
The integration of care for BU and leprosy prompted new conceptualisations of these diseases and experiences of NTD stigma. Some patients felt anxiety about using services because they feared being infected with the other disease. Other patients viewed the two diseases as 'intertwined': related manifestations of the same condition. Configurations of inter-disease stigma due to fear of transmission were buffered by joint health education sessions which also appeared to facilitate social support between patients in the facility. For both diseases, medication and wound care were viewed as the cornerstones of care and appreciated as interventions that led to rehabilitation of the whole patient group through shared experiences of healing, avoidance of physical deformities and stigma reduction. Patient accounts of intense pain during wound care for BU and inability of staff to manage severe complications, however, exposed some shortcomings of medical care for the newly integrated service, as did patient fears of long-lasting disability due to lack of physiotherapy services.
SIGNIFICANCE
Under integrated care policies, the possibility of new discourses about skin NTD identities emerging along with new configurations of stigma may have unanticipated consequences for patients' experiences of case management. The social experience of integrated medication and wound dressing has the potential to link patients within a single, supportive patient community. Control programmes with resource constraints should anticipate potential challenges of integrating care, including the need to ameliorate lasting disability and provide adequate clinical management of severe BU cases.

Identifiants

pubmed: 32023242
doi: 10.1371/journal.pntd.0008030
pii: PNTD-D-19-01195
pmc: PMC7001903
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0008030

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Health Res Policy Syst. 2010 Oct 21;8:32
pubmed: 20961461
PLoS Negl Trop Dis. 2017 Jan 19;11(1):e0005136
pubmed: 28103250
Lancet. 2006 Feb 11;367(9509):528-9
pubmed: 16473129
Trans R Soc Trop Med Hyg. 2016 Dec 1;110(12):679-680
pubmed: 28938054
Lancet. 1998 Sep 26;352(9133):1054-5
pubmed: 9759769
Infect Dis Poverty. 2014 Oct 01;3(1):35
pubmed: 25320672
BMC Public Health. 2018 Jan 30;18(1):201
pubmed: 29382314
Int Health. 2016 Mar;8 Suppl 1:i53-70
pubmed: 26940310
Infect Dis Poverty. 2014 Jul 31;3:24
pubmed: 25114794
Psychol Health Med. 2006 Aug;11(3):277-87
pubmed: 17130065
Soc Sci Med. 2016 Feb;151:139-46
pubmed: 26802370
Trop Med Infect Dis. 2018 Nov 14;3(4):
pubmed: 30441754
PLoS Med. 2018 Feb 20;15(2):e1002508
pubmed: 29462138
PLoS Negl Trop Dis. 2019 Sep 6;13(9):e0007710
pubmed: 31490931
Int J Dermatol. 2017 Dec;56(12):1432-1437
pubmed: 29057458
Bull World Health Organ. 2017 Sep 1;95(9):652-656
pubmed: 28867846
PLoS Negl Trop Dis. 2010 May 25;4(5):e718
pubmed: 20520793
PLoS Negl Trop Dis. 2016 Jul 01;10(7):e0004602
pubmed: 27367809
N Engl J Med. 2007 Sep 6;357(10):1018-27
pubmed: 17804846
PLoS Negl Trop Dis. 2010 Jun 29;4(6):e755
pubmed: 20614017
PLoS Negl Trop Dis. 2008 May 14;2(5):e237
pubmed: 18478049
Trop Med Infect Dis. 2018 Sep 10;3(3):
pubmed: 30274497
Trends Parasitol. 2007 Nov;23(11):511-4
pubmed: 17951109
Indian J Lepr. 2010 Oct-Dec;82(4):189-94
pubmed: 21434595
Infect Dis Poverty. 2017 May 1;6(1):52
pubmed: 28457226
Trends Parasitol. 2016 Nov;32(11):843-854
pubmed: 27638231
PLoS Negl Trop Dis. 2015 Oct 20;9(10):e0004003
pubmed: 26485128
Am J Trop Med Hyg. 1998 Dec;59(6):1015-22
pubmed: 9886216

Auteurs

Mateo Prochazka (M)

Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Joseph Timothy (J)

Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Rachel Pullan (R)

Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Karsor Kollie (K)

Liberia Ministry of Health and Social Welfare, Monrovia, Liberia.

Emerson Rogers (E)

Liberia Ministry of Health and Social Welfare, Monrovia, Liberia.

Abednego Wright (A)

Liberia Ministry of Health and Social Welfare, Monrovia, Liberia.

Jennifer Palmer (J)

Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH